Skip to content

Patients › General-Health

Inyecciones de cortisona y corticosteroides

What cortisone injections do, when they help, how long the effect lasts, and the risks of repeated injections for shoulder, elbow, wrist and hand conditions.

Updated Sep 2026
Una jeringa para administrar una inyección de cortisona en la parte anterior del hombro.
Una inyección de corticosteroide puede reducir la inflamación en una articulación o tendón, aliviando el dolor y favoreciendo la rehabilitación. Kieran Hirpara 4.0

Esta página se tradujo automáticamente y todavía no la ha revisado un médico. La versión en inglés es la versión oficial.

¿Qué es?

La inyección de cortisona es un potente medicamento antiinflamatorio que el médico inyecta en una articulación, tendón o zona nerviosa dolorosa. “Cortisona” es el nombre común para los corticosteroides, una versión sintética de una hormona que el cuerpo produce naturalmente para reducir la inflamación. El medicamento se administra mediante una sola inyección a través de la piel, generalmente con una aguja fina; actúa precisamente en el lugar donde se aplica, sin distribuirse por todo el cuerpo.

Su médico puede recomendar este tratamiento para diversos problemas de la mano, muñeca, codo y hombro. Entre ellos se incluyen el dedo en gatillo (un dedo que se traba o se bloquea al doblarse), el síndrome del túnel carpiano (presión sobre un nervio que provoca hormigueo y entumecimiento), el codo de tenista, la enfermedad de De Quervain (dolor en el lado del pulgar de la muñeca), los quistes ganglionares y la artritis en la base del pulgar. También se utiliza para problemas del hombro como el desgarro del manguito rotador, el hombro congelado y el síndrome de pinzamiento; en ocasiones, para la fascitis plantar, que causa dolor en la parte inferior del talón.

La inyección reduce la hinchazón e irritación del tejido alrededor de la zona dolorida. Al disminuir la inflamación, suele disminuir también el dolor y se recupera mayor libertad de movimiento. En algunas afecciones, el alivio es temporal; por ello, a veces se combina con otros tratamientos como el uso de férulas, ejercicios o terapia manual. Su médico le explicará si la inyección es adecuada para su condición y sus objetivos, así como qué esperar si el dolor reaparece posteriormente.

¿Funciona?

Las inyecciones de cortisona resultan eficaces para algunas afecciones y menos para otras. En el caso del hombro congelado, los estudios demuestran que una inyección en la articulación alivia el dolor, mejora el funcionamiento del hombro y aumenta el rango de movimiento [1]. En la enfermedad de De Quervain, el dolor y los resultados clínicos mejoraron significativamente tras la inyección [2]. En la artritis de la base del pulgar, las inyecciones de esteroides aportan beneficios a corto plazo [3].

En el síndrome del túnel carpiano, la inyección alivia los síntomas de forma segura durante un tiempo, pero la mayoría de los pacientes acaban necesitando cirugía para un control a largo plazo [4]. En comparación con un placebo (una inyección simulada), mejoró los síntomas al mes de aplicarse; además, resultó más eficaz que los comprimidos de esteroides durante hasta 3 meses [5]. Pasadas 8 semanas, no mostró mejores resultados que el tratamiento antiinflamatorio, el uso de férulas o el tratamiento láser [5].

En el caso del codo de tenista, los resultados son más variados. Las inyecciones de esteroides ayudan temporalmente, pero ese beneficio se invierte a las seis semanas y el dolor suele reaparecer [6]. Si sus síntomas llevan menos de 12 meses presentes, generalmente no se recomiendan las inyecciones de esteroides [7]. Otros tratamientos pueden ser más duraderos: el plasma rico en plaquetas (elaborado a partir de su propia sangre) no presentó ventajas sobre los esteroides durante el primer mes, pero obtuvo mejores resultados a los 3 y 6 meses [8].

En el caso del dedo en gatillo, el tipo de esteroide empleado es importante. Un estudio reveló que la betametasona perdió eficacia antes que la triamcinolona cuando se usaba como primera inyección [9]. En problemas del manguito rotador, los esteroides resultaron más útiles a corto plazo, mientras que el plasma rico en plaquetas pareció ser mejor para la recuperación a largo plazo [10]. Asimismo, no se hallaron pruebas concluyentes de que una única inyección previa a la cirugía de reparación del manguito rotador aumente el riesgo de fracaso de la reparación o de infección [11].

Quedan aún algunas dudas sin resolver. No existen pruebas sólidas de que el uso de ecografía u otras técnicas de imagen para guiar la aguja mejore los resultados en la artritis de la base del pulgar [12]. Por otro lado, las personas con diabetes tienen menos probabilidades de obtener éxito con una sola inyección para la enfermedad de De Quervain; no obstante, las inyecciones repetidas siguen siendo efectivas [13].

¿Cuáles son los riesgos?

La mayoría de las personas solo experimentan efectos a corto plazo en el lugar de la inyección. La aguja puede causar dolor; además, investigaciones sobre el dedo en gatillo demostraron que mezclar el esteroide con un anestésico (lidocaína) reduce el dolor durante y poco después de la inyección, aunque esta diferencia quizás no sea muy relevante en la práctica [1]. Algunos efectos aparecen más tarde. En el caso del codo de tenista, estudios indican que las inyecciones de esteroides pueden provocar acumulación de calcio en el tejido blando del sitio de aplicación; esto probablemente sea una complicación derivada de la propia inyección [2].

El medicamento también puede afectar otras partes del cuerpo. Si padece diabetes tipo 2 y no usa insulina, una inyección en el hombro puede elevar considerablemente sus niveles de azúcar en sangre durante un breve período [3]. Si tiene diabetes y está recibiendo tratamiento para la enfermedad de De Quervain, una sola inyección tiene menos probabilidades de éxito que en personas sin diabetes; sin embargo, las inyecciones repetidas siguen siendo efectivas [4].

Algunas preocupaciones han sido analizadas directamente y no se han confirmado. En el caso de la reparación del manguito rotador, investigaciones no hallaron evidencia clara de que las inyecciones aumenten el riesgo de que la reparación se rompa nuevamente o de infección [5]. En cirugías de liberación del túnel carpiano, las inyecciones previas, en cualquier momento estudiado, no se asociaron a una mayor tasa de infecciones profundas posteriormente [6]. Las inyecciones repetidas para el síndrome del túnel carpiano resultaron ser seguras; tampoco dificultaron ni incrementaron los riesgos de una cirugía futura [7].

La frecuencia con la que se puede aplicar una inyección depende de la afección. En el caso del dedo en gatillo, un estudio no reportó complicaciones al administrar 4 mg de triamcinolona con intervalos mínimos de un mes entre cada inyección [8]. Tras una reparación del manguito rotador, las inyecciones deben posponerse al menos hasta el primer mes postoperatorio para reducir el riesgo de efectos adversos [9]. En la enfermedad de De Quervain, dirigir la inyección a un compartimento tendinoso más pequeño permite usar una dosis menor de esteroide, lo que podría disminuir las complicaciones [10].

La evidencia sobre algunos aspectos es limitada o contradictoria; su médico evaluará lo conocido en relación con su condición específica antes de recomendarle una inyección.

¿Es adecuado para usted?

Una inyección podría ser una buena opción si desea un alivio a corto plazo mientras otros tratamientos, como el uso de férulas o la terapia de la mano, hacen efecto. Suele ser de mayor ayuda cuando la hinchazón es el principal factor que causa su dolor; en algunos casos, puede retrasar o incluso evitar la cirugía por un tiempo. En el caso de la artritis en la base del pulgar, los estudios demuestran que las inyecciones son una opción práctica, pues son eficaces, fáciles de aplicar y sencillas de obtener [1].

Sin embargo, quizás no sea adecuada si sus síntomas ya duran mucho tiempo. En el caso del codo de tenista, por lo general no se recomiendan las inyecciones de esteroides si los síntomas llevan menos de 12 meses presentándose [2]. Además, cuando el dolor tiende a reaparecer, como ocurre en el codo de tenista, usted y su médico podrían considerar otras opciones que ofrezcan mejores resultados a lo largo de meses en lugar de semanas. Un estudio comparativo concluyó que, al cabo de un mes, los esteroides resultan más eficaces que el plasma rico en plaquetas para el codo de tenista; sin embargo, a los 6 meses el plasma rico en plaquetas muestra mejores resultados [3].

En algunas afecciones, las inyecciones repetidas constituyen una alternativa viable. En el síndrome del túnel carpiano, los estudios indican que aplicarlas en varias ocasiones es seguro y no dificulta ni eleva el riesgo de una cirugía de liberación posterior [4].

La toma de decisiones es un proceso conjunto. Su médico evaluará su condición, su estado de diabetes si aplica, así como sus objetivos, y luego analizará si una inyección, otro tratamiento o la cirugía es la mejor opción para usted. La sección de riesgos anterior detalla posibles complicaciones; por ello, le recomendamos leerla antes de decidir.

Conclusión

Vale la pena considerar una inyección de cortisona cuando se busca alivio mientras otros tratamientos hacen efecto. En algunos problemas, como el hombro congelado, reduce el dolor y facilita el movimiento [1]. En otros, como el codo de tenista, el alivio desaparece rápidamente y el dolor suele volver [2]. La advertencia más importante: pregunte cuánto tiempo es probable que dure el beneficio para su condición, y qué haría a continuación si el dolor regresara.

Referencias

[1] Inyección intraarticular de esteroides para el hombro congelado: una revisión sistemática y metaanálisis de ensayos controlados aleatorizados con análisis secuencial de ensayos. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516669944

[2] Comparación prospectiva y aleatorizada entre la inyección de corticosteroides guiada por ecografía y la inyección ciega para la enfermedad de De Quervain. Orthopaedics & Traumatology: Surgery & Research. 2020. DOI: 10.1016/j.otsr.2019.11.015

[3] Inyecciones intraarticulares de corticosteroides para el manejo de la artrosis trapeciometacarpiana: una revisión sistemática. HAND. 2015. DOI: 10.1007/s11552-015-9778-3

[4] Inyección de corticosteroides para el síndrome del túnel carpiano. The Journal of Hand Surgery. 2008. DOI: 10.1016/j.jhsa.2008.06.023

[5] Sección Cochrane: inyección local de corticosteroides para el síndrome del túnel carpiano. Journal of Hand Surgery (European Volume). 2013. DOI: 10.1177/1753193413490848

[6] Movilización con ejercicios, inyección de corticosteroides o esperar para observar en el codo de tenista: ensayo aleatorizado. BMJ. 2006. DOI: 10.1136/bmj.38961.584653.ae

[7] Dejen de inyectar corticosteroides en pacientes con codo de tenista; es mucho más probable que mejoren por sí solos. Journal of Science and Medicine in Sport. 2010. DOI: 10.1016/j.jsams.2009.09.009

[8] Las inyecciones de corticosteroides para el tratamiento de la epicondilitis lateral son superiores al plasma rico en plaquetas a los 1 mes; sin embargo, el plasma rico en plaquetas resulta más eficaz a los 6 meses: una revisión sistemática y metaanálisis actualizado de estudios de nivel 1 y 2. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.04.018

[9] Efecto del tipo de corticosteroide sobre el fracaso tras la inyección inicial para el dedo en gatillo. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2026.03.011

[10] Comparación de los efectos del plasma rico en plaquetas y la inyección de corticosteroides en el tratamiento de la enfermedad del manguito rotador: una revisión sistemática y metaanálisis. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.01.037

[11] ¿Las inyecciones de corticosteroides antes o después de la reparación primaria del manguito rotador influyen en la incidencia de eventos adversos? Una síntesis subjetiva. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.01.039

[12] Inyección guiada de esteroides para la artrosis de la articulación carpometacarpiana del pulgar: una revisión exploratoria. Hand Therapy. 2026. DOI: 10.1177/17589983261430876

[13] Eficacia de las inyecciones de corticosteroides en pacientes diabéticos con tenosinovitis de De Quervain. The Journal of Hand Surgery. 2022. DOI: 10.1016/j.jhsa.2022.02.018

[14] Inyección de corticosteroides con y sin anestésico local para el tratamiento del dedo en gatillo: un ensayo clínico aleatorizado. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.05.016

[15] Asociación entre la inyección de esteroides y la calcificación de tejidos blandos en la epicondilitis lateral. Journal of Shoulder and Elbow Surgery. 2019. DOI: 10.1016/j.jse.2018.10.009

[16] Efecto de la inyección de esteroides en el hombro sobre la glucemia en pacientes con diabetes tipo 2. JSES International. 2022. DOI: 10.1016/j.jseint.2022.05.016

[17] La inyección preoperatoria ipsilateral de corticosteroides y el momento de su aplicación no se asocian con infección profunda postoperatoria tras la liberación del túnel carpiano. Journal of the American Academy of Orthopaedic Surgeons. 2025. DOI: 10.5435/jaaos-d-25-00317

[18] Seguridad y costo de las inyecciones repetidas de corticosteroides para el síndrome del túnel carpiano. Journal of Hand Surgery (European Volume). 2025. DOI: 10.1177/17531934251396629

[19] Seguridad y eficacia de la inyección de dosis bajas de triamcinolona sin limitación en la frecuencia de aplicación para el dedo en gatillo. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.01.005

[20] Las inyecciones de corticosteroides tras la reparación del manguito rotador mejoran la función, reducen el dolor y son seguras: una revisión sistemática. Arthroscopy, Sports Medicine, and Rehabilitation. 2021. DOI: 10.1016/j.asmr.2021.10.010

[21] ¿Es más eficaz la inyección de esteroides en ambos compartimentos que la inyección únicamente en el subcompartimento del músculo extensor corto del pulgar en pacientes con enfermedad de De Quervain? Un estudio aleatorizado y controlado. Clinical Orthopaedics & Related Research. 2021. DOI: 10.1097/corr.0000000000002018

[22] Eficacia de la inyección intraarticular de corticoides para el tratamiento no quirúrgico de la artrosis trapeciometacarpiana: una revisión sistemática y metaanálisis de ensayos controlados aleatorizados. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2024.02.001


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

Efficacy by Condition

  • Corticosteroid injections are effective in 57% of patients with trigger finger [10].
  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores in rotator cuff repair patients [3].
  • Corticosteroids are a favorable option for the management of trapeziometacarpal osteoarthritis given their affordability, ease of administration, and efficacy [11].
  • When corticosteroid injection is used to treat adhesive capsulitis, both intra-articular and subacromial injection sites can be selected [15].

Steroid Type and Dosing

  • Betamethasone injections resulted in a significantly shorter time to failure than triamcinolone injections for primary trigger finger [1].
  • Triamcinolone is supported as a more viable corticosteroid option for shoulder injection compared to methylprednisolone [4].
  • An injection targeting the extensor pollicis brevis subcompartment alone in de Quervain disease can reduce the dose of steroids used, potentially decreasing complications [8].
  • No complications were observed for 4 mg triamcinolone injections for trigger finger when administered at intervals of at least 1 month [12].

Safety and Timing

  • Corticosteroid injections should be administered only after the first postoperative month following rotator cuff repair to minimize the potential risk for adverse events [2].
  • An interval of at least three months is recommended between corticosteroid injection and shoulder arthroplasty [19].
  • There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use based on a subjective synthesis of ranges [5].

Contraindications

  • Corticosteroid injections should not be used to treat most patients with tennis elbow with symptom duration of less than 12 months [6].

How It Works

Efficacy and Outcomes by Condition

  • Local corticosteroid injection provides greater clinical improvement in symptoms 1 month after injection compared with placebo for carpal tunnel syndrome [13].
  • Local corticosteroid injection provides significantly greater improvement than oral corticosteroid for up to 3 months for carpal tunnel syndrome [13].
  • Local corticosteroid injection does not significantly improve outcomes compared with anti-inflammatory treatment, splinting, or laser treatment beyond 8 weeks for carpal tunnel syndrome [13].
  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores after rotator cuff repair [3].
  • The significant short term benefits of corticosteroid injection for tennis elbow are reversed after six weeks, with high recurrence rates [9].
  • Combining a corticosteroid injection with exercise is not superior to exercise or no exercise for plantar fasciopathy [7].

Steroid Type and Dosing

  • An injection targeting the extensor pollicis brevis subcompartment alone can reduce the dose of steroids used in de Quervain disease [8].

Safety and Complications

  • No complications were observed for 4 mg triamcinolone injections when administered at intervals of at least 1 month for trigger finger [12].
  • Local corticosteroid injection to the shoulder can create a significant, short-term increase in systemic glucose levels in patients with type 2 diabetes not treated with insulin [20].
  • Serial saline solution injections are a promising, cost-effective, and low-risk treatment option for subcutaneous lipoatrophy and skin depigmentation following cortisone injection in the elbow [17].

Timing and Surgical Context

  • Corticosteroid injections should be administered only after the first postoperative month to minimize the potential risk for adverse events following rotator cuff repair [2].
  • Preoperative corticosteroid injection at all studied timepoints was not associated with an increased risk of postoperative deep infection after carpal tunnel release [16].

Contraindications and Cautions

  • Corticosteroid injection for tennis elbow should be used with caution due to high recurrence rates after six weeks [9].

What the Evidence Shows

Trigger Finger

  • Betamethasone injections resulted in a significantly shorter time to failure than triamcinolone injections [1].
  • There is a statistically significant difference in pain during and shortly after injection when using a steroid with lidocaine versus steroid alone, but that difference may not be clinically relevant [27].

Lateral Epicondylitis (Tennis Elbow)

  • The significant short term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates, implying that this treatment should be used with caution in the management of tennis elbow [9].
  • A single, blinded injection of corticosteroid medication was associated with poorer long-term outcomes and higher recurrence rates 1 year after receiving an injection in patients with unilateral lateral epicondylalgia [22].
  • Corticosteroid injections for the treatment of lateral epicondylitis are superior to platelet-rich plasma at 1 month [18].
  • Platelet-rich plasma is more effective than corticosteroid injections at 6 months for the treatment of lateral epicondylitis [18].
  • Platelet-rich plasma is superior to corticosteroid injections at 3 months for the treatment of lateral epicondylitis [18].

Rotator Cuff

  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores in rotator cuff disease [3].
  • There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use based on a subjective synthesis of ranges regarding rotator cuff repair [5].
  • Timing of a single preoperative corticosteroid injection within 1 year of rotator cuff repair did not significantly affect failure rates, patient-reported outcomes, range of motion, or strength [26].
  • Corticosteroids have better efficacy in short term for rotator cuff disease treatment compared to platelet-rich plasma [23].
  • Platelet-rich plasma is more beneficial for longterm recovery in rotator cuff disease treatment compared to corticosteroids [23].

Shoulder (General)

  • Intra-articular steroid injection is effective and safe for frozen shoulder, relieving pain, improving functional performance, and increasing range of motion [25].

Carpal Tunnel Syndrome

  • Local corticosteroid injection provides greater clinical improvement in symptoms 1 month after injection compared with placebo [13].
  • Corticosteroid injection is safe and effective for the temporary relief of carpal tunnel syndrome symptoms [24].
  • Most patients with carpal tunnel syndrome will eventually require surgery for long-term control of their symptoms despite corticosteroid injection [24].

Thumb Carpometacarpal Joint

  • Corticosteroids are a favorable option when considering the choice of intra-articular injection for the management of trapeziometacarpal osteoarthritis given their affordability, ease of administration, and efficacy [11].
  • There is lack of robust evidence to support use of image guidance to improve accuracy and clinical effectiveness of steroid injection for thumb carpometacarpal joint osteoarthritis [14].

Plantar Fasciopathy

  • Combining a corticosteroid injection with exercise is not superior to exercise or no exercise for patients with plantar fasciopathy [7].

Practical Considerations

Steroid Selection and Dosing

  • An injection targeting the extensor pollicis brevis subcompartment alone in de Quervain disease can reduce the dose of steroids used, potentially decreasing complications related to steroid injections [8].

Timing and Frequency

  • Corticosteroid injections after rotator cuff repair should be administered only after the first postoperative month to minimize the potential risk for adverse events [2].

Efficacy and Outcomes

  • Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores following rotator cuff repair [3].
  • Combining a corticosteroid injection with exercise for plantar fasciopathy is not superior to exercise or no exercise [7].
  • Corticosteroids are a favorable option for intra-articular injection in the management of trapeziometacarpal osteoarthritis given their affordability, ease of administration, and efficacy [11].
  • Platelet-rich plasma has no advantage over steroid injections within the first month of treatment for lateral epicondylitis, but it is superior to steroids at both 3 and 6 months [18].

Safety and Complications

  • There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use before or after primary rotator cuff repair based on a subjective synthesis of ranges [5].
  • Corticosteroid and hyaluronic acid injections remain a safe treatment option regarding the risk of severe adverse events requiring hospitalization [21].

Imaging Guidance

  • There is a lack of robust evidence to support the use of image guidance to improve accuracy and clinical effectiveness of steroid injection for thumb carpometacarpal joint osteoarthritis [14].

Key Evidence

  • [L3] Betamethasone injections resulted in a significantly shorter time to failure than triamcinolone injections. [1] (10.1016/j.jhsa.2026.03.011)
  • [L1] Corticosteroid injections should be administered only after the first postoperative month to minimize the potential risk for adverse events. [2] (10.1016/j.asmr.2021.10.010)
  • [L4] Corticosteroid injections provide benefit by relieving pain and improving functional outcome scores. [3] (10.1016/j.arthro.2020.04.044)
  • [L2] This study supports TA as a more viable corticosteroid option for shoulder injection. [4] (10.1016/j.jse.2023.05.023)
  • [L3] There were no conclusive data to suggest an increased risk of retear or infection with corticosteroid injection use based on a subjective synthesis of ranges. [5] (10.1016/j.arthro.2020.01.039)
  • [Paper] Corticosteroid injections should not be used to treat most patients with tennis elbow with symptom duration of less than 12 months. [6] (10.1016/j.jsams.2009.09.009)
  • [L1] The results indicate that combining a corticosteroid injection with exercise is not superior to exercise or no exercise. [7] (10.1136/bjsports-2023-106948)
  • [L1] An injection targeting the EPB subcompartment alone can reduce the dose of steroids used, perhaps thereby decreasing complications related to steroid injections. [8] (10.1097/corr.0000000000002018)
  • [L1] The significant short term benefits of corticosteroid injection are paradoxically reversed after six weeks, with high recurrence rates, implying that this treatment should be used with caution in the management of tennis elbow. [9] (10.1136/bmj.38961.584653.ae)
  • [L1] Corticosteroid injections are effective in 57% of patients with trigger finger. [10] (10.5435/00124635-200703000-00006)
  • [L1] Given the affordability, ease of administration, and efficacy associated with corticosteroids, they are a favorable option when considering the choice of intra-articular injection for the management of TMC OA. [11] (10.1016/j.jhsa.2024.02.001)
  • [L4] No complications were observed for 4 mg triamcinolone injections when administered at intervals of at least 1 month. [12] (10.1016/j.jhsg.2025.01.005)
  • [L1] Local corticosteroid injection provides greater clinical improvement in symptoms 1 month after injection compared with placebo and significantly greater improvement than oral corticosteroid for up to 3 months, but does not significantly improve outcomes compared with anti-inflammatory treatment, splinting, or laser treatment beyond 8 weeks. [13] (10.1177/1753193413490848)
  • [L4] However, there is lack of robust evidence to support use of image guidance to improve accuracy and clinical effectiveness of steroid injection for thumb CMCJ and warrants further research. [14] (10.1177/17589983261430876)
  • [L1] When corticosteroid injection is used to treat adhesive capsulitis, both injection sites can be selected. [15] (10.1155/2019/1274790)
  • [L3] Preoperative corticosteroid injection at all studied timepoints was not associated with an increased risk of postoperative deep infection, a divergence from existing literature. [16] (10.5435/jaaos-d-25-00317)
  • [L4] Serial saline solution injections are a promising, cost-effective, and low-risk treatment option for subcutaneous lipoatrophy and skin depigmentation following cortisone injection in the elbow. [17] (10.1016/j.jseint.2020.08.009)
  • [L1] PRP has no advantage over steroid injections within the first month of treatment, but it is superior to steroids at both 3 and 6 months. [18] (10.1016/j.jse.2023.04.018)
  • [L1] Thus, an interval of at least three months is recommended between injection and arthroplasty. [19] (10.1177/17585732241261659)
  • [L2] Local corticosteroid injection to the shoulder can create a significant, short-term increase in systemic glucose levels in patients with type 2 diabetes not treated with insulin. [20] (10.1016/j.jseint.2022.05.016)
  • [L2] Corticosteroid and hyaluronic acid injections remain a safe treatment option regarding the risk of severe adverse events requiring hospitalization. [21] (10.1186/s12891-026-09752-7)
  • [L1] A single, blinded injection of corticosteroid medication was associated with poorer long-term outcomes and higher recurrence rates 1 year after receiving an injection in patients with unilateral lateral epicondylalgia. [22] (10.1001/jama.2013.129)
  • [L1] Current analysis showed that corticosteroids have better efficacy in short term, whereas PRP is more beneficial for longterm recovery. [23] (10.1016/j.jse.2023.01.037)
  • [L5] Corticosteroid injection is safe and effective for the temporary relief of carpal tunnel syndrome symptoms, but most patients will eventually require surgery for long-term control of their symptoms. [24] (10.1016/j.jhsa.2008.06.023)
  • [L1] Intra-articular steroid injection is effective and safe for frozen shoulder, relieving pain, improving functional performance, and increasing range of motion. [25] (10.1177/0363546516669944)
  • [L2] Timing of a single preoperative corticosteroid injection within 1 year of rotator cuff repair did not significantly affect failure rates, patient-reported outcomes, range of motion, or strength, suggesting that one injection before repair does not strongly influence outcomes. [26] (10.1016/j.jseint.2026.101632)
  • [L2] There is a statistically significant difference in pain during and shortly after injection when using a steroid with lidocaine versus steroid alone, but that difference may not be clinically relevant. [27] (10.1016/j.jhsa.2024.05.016)

References

[1] The Effect of Corticosteroid Type on Failure Following Primary Trigger Finger Injection. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2026.03.011

[2] Corticosteroid Injections After Rotator Cuff Repair Improve Function, Reduce Pain, and Are Safe: A Systematic Review. Arthroscopy, Sports Medicine, and Rehabilitation. 2021. DOI: 10.1016/j.asmr.2021.10.010

[3] Corticosteroid Injections May Increase Retear and Revision Rates of Rotator Cuff Repair: A Systematic Review. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.04.044

[4] Comparison of triamcinolone and methylprednisolone efficacy and steroid flare reaction rates after shoulder corticosteroid injection: a prospective interrupted time series study. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.05.023

[5] Do Corticosteroid Injections Before or After Primary Rotator Cuff Repair Influence the Incidence of Adverse Events? A Subjective Synthesis. Arthroscopy. 2020. DOI: 10.1016/j.arthro.2020.01.039

[6] Stop injecting corticosteroid into patients with tennis elbow, they are much more likely to get better by themselves!. Journal of Science and Medicine in Sport. 2010. DOI: 10.1016/j.jsams.2009.09.009

[7] Does a corticosteroid injection plus exercise or exercise alone add to the effect of patient advice and a heel cup for patients with plantar fasciopathy? A randomised clinical trial. British Journal of Sports Medicine. 2023. DOI: 10.1136/bjsports-2023-106948

[8] Is a Steroid Injection in Both Compartments More Effective than an Injection in the Extensor Pollicis Brevis Subcompartment Alone in Patients with de Quervain Disease? A Randomized, Controlled Trial. Clinical Orthopaedics & Related Research. 2021. DOI: 10.1097/corr.0000000000002018

[9] Mobilisation with movement and exercise, corticosteroid injection, or wait and see for tennis elbow: randomised trial. BMJ. 2006. DOI: 10.1136/bmj.38961.584653.ae

[10] Corticosteroid Injections in the Treatment of Trigger Finger: A Level I and II Systematic Review. Journal of the American Academy of Orthopaedic Surgeons. 2007. DOI: 10.5435/00124635-200703000-00006

[11] Efficacy of Intra-Articular Corticosteroid Injection for Nonsurgical Management of Trapeziometacarpal Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2024.02.001

[12] Safety and Efficacy of Low-Dose Triamcinolone Injection without Injection Frequency Limitation for Trigger Finger. Journal of Hand Surgery Global Online. 2025. DOI: 10.1016/j.jhsg.2025.01.005

[13] Cochrane corner: local corticosteroid injection for carpal tunnel syndrome. Journal of Hand Surgery (European Volume). 2013. DOI: 10.1177/1753193413490848

[14] Guided steroid injection for thumb carpometacarpal joint (CMCJ) osteoarthritis: A scoping review. Hand Therapy. 2026. DOI: 10.1177/17589983261430876

[15] Intra-Articular versus Subacromial Corticosteroid Injection for the Treatment of Adhesive Capsulitis: A Meta-Analysis and Systematic Review. BioMed Research International. 2019. DOI: 10.1155/2019/1274790

[16] Ipsilateral Preoperative Corticosteroid Injection and Timing Not Associated With Postoperative Deep Infection After Carpal Tunnel Release. Journal of the American Academy of Orthopaedic Surgeons. 2025. DOI: 10.5435/jaaos-d-25-00317

[17] Serial saline solution injections for the treatment of lipoatrophy and depigmentation after corticosteroid injection for medial epicondylitis. JSES International. 2020. DOI: 10.1016/j.jseint.2020.08.009

[18] Corticosteroid injections for the treatment of lateral epicondylitis are superior to platelet-rich plasma at 1 month but platelet-rich plasma is more effective at 6 months: an updated systematic review and meta-analysis of level 1 and 2 studies. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.04.018

[19] The safety of corticosteroid injection prior to shoulder arthroplasty: A systematic review. Shoulder & Elbow. 2024. DOI: 10.1177/17585732241261659

[20] The effect of steroid injection into the shoulder on glycemia in patients with type 2 diabetes. JSES International. 2022. DOI: 10.1016/j.jseint.2022.05.016

[21] Safety of intra-articular corticosteroid and hyaluronic acid injections: a 14-year population-based cohort study of 404,797 patients. BMC Musculoskeletal Disorders. 2026. DOI: 10.1186/s12891-026-09752-7

[22] Effect of Corticosteroid Injection, Physiotherapy, or Both on Clinical Outcomes in Patients With Unilateral Lateral Epicondylalgia. JAMA. 2013. DOI: 10.1001/jama.2013.129

[23] Comparison of the effects of platelet-rich plasma and corticosteroid injection in rotator cuff disease treatment: a systematic review and meta-analysis. Journal of Shoulder and Elbow Surgery. 2023. DOI: 10.1016/j.jse.2023.01.037

[24] Corticosteroid Injection for Carpal Tunnel Syndrome. The Journal of Hand Surgery. 2008. DOI: 10.1016/j.jhsa.2008.06.023

[25] Intra-articular Steroid Injection for Frozen Shoulder: A Systematic Review and Meta-analysis of Randomized Controlled Trials With Trial Sequential Analysis. The American Journal of Sports Medicine. 2016. DOI: 10.1177/0363546516669944

[26] Timing of corticosteroid injection within 1 year prior to rotator cuff repair was not associated with increased risk of repair failure. JSES International. 2026. DOI: 10.1016/j.jseint.2026.101632

[27] Corticosteroid Injection With and Without Local Anesthetic for the Treatment of Trigger Finger: A Randomized Clinical Trial. The Journal of Hand Surgery. 2025. DOI: 10.1016/j.jhsa.2024.05.016

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.